Anbio introduces cutting-edge “Point of Care” technology in Europe
Anbio Biotechnology is expanding into the European market with its star product AF-100 C, a ground-breaking compact fluorescent immunoassay analyzer, which is to revolutionize point-of-care testing. With over 70 assays, the AF-100 C aims to empower healthcare providers in the EU, enhancing patient care and prognosis. FRANKFURT, Germany. April 8th, 2024 – In a strategic […]
Anbio introduces cutting-edge “Point of Care” technology in Europe Read More »